Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Prednisolone for Induction of Remission in Lupus Nephritis
NCT04146220Phase 4Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jul 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisolone in lupus nephritis (LN) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Complete Renal Remission at 24 weeks. Started Jul 2018; status: completed.
02
Drugs
prednisolone
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT04146220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04146220.